BCHE and Alzheimer disease: The numbers of subjects in the AD group receiving pharmacological interventions were as follows: cholinesterase inhibitors (n = 19), N‐methyl‐D‐aspartate (NMDA) receptor antagonists (n = 9), and other agents (sodium oligomannate, nicergoline) (n = 4).